ClinicalTrials.Veeva

Menu

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

N

Norwegian University of Science and Technology

Status and phase

Completed
Phase 3

Conditions

Alcoholism
Substance-Related Disorders

Treatments

Other: intranasal spray without oxytocin
Drug: intranasal oxytocin spray

Study type

Interventional

Funder types

Other

Identifiers

NCT03339024
2015-004463-37 (EudraCT Number)
2016/45

Details and patient eligibility

About

This study is an assessment of the long-term effect of oxytocin nasal spray on alcohol withdrawal and dependence in adults admitted for detoxification of alcohol after 60 days and 1 year. It is a follow-up study of a placebo-controlled randomized controlled study where subjects used oxytocin nasal spray during acute withdrawal and the following 4 weeks in an outpatient setting. Half of the participants have received oxytocin nasal spray, the other half placebo nasal spray (NCT02903251). (added March 2019: 24 patients were available for 1-year follow-up)

Enrollment

38 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • participants in the RCT (NCT02903251) who completed the study

Exclusion criteria

  • participants in the RCT (NCT02903251) who did not complete the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

38 participants in 2 patient groups, including a placebo group

oxytocin
Experimental group
Description:
intranasal oxytocin spray Day 1-3: Twice daily intranasal oxytocin spray administered by health personnel. Day 3-30:Self-administered intranasal spray as needed, max thrice daily
Treatment:
Drug: intranasal oxytocin spray
Placebo
Placebo Comparator group
Description:
intranasal spray without oxytocin Day 1-3: Twice daily intranasal spray without oxytocin, administered by health personnel. Day 3-30: Self-administered intranasal spray as needed, max thrice daily
Treatment:
Other: intranasal spray without oxytocin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems